↓ Skip to main content

Dove Medical Press

Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment

Overview of attention for article published in OncoTargets and therapy, June 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
19 Mendeley
Title
Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
Published in
OncoTargets and therapy, June 2019
DOI 10.2147/ott.s205097
Pubmed ID
Authors

Lin-Wen Wu, Jian-Kang Zhang, Mingjun Rao, Zuo-Yan Zhang, Hua-Jian Zhu, Chong Zhang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 16%
Researcher 3 16%
Student > Master 2 11%
Student > Bachelor 1 5%
Student > Ph. D. Student 1 5%
Other 2 11%
Unknown 7 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 42%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Agricultural and Biological Sciences 1 5%
Chemistry 1 5%
Unknown 7 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2022.
All research outputs
#8,694,310
of 25,759,158 outputs
Outputs from OncoTargets and therapy
#564
of 3,014 outputs
Outputs of similar age
#146,249
of 364,974 outputs
Outputs of similar age from OncoTargets and therapy
#16
of 111 outputs
Altmetric has tracked 25,759,158 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,014 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.